Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

AACR news: squalamine evaluated for activity in prostate and lung cancer models

April 20, 1999

Potent and long-lasting GnRH antagonist presented by Ferring

April 20, 1999

FDA grants priority review status to Alza' sNDA for Doxil in ovarian cancer

April 20, 1999

SBR-170: a new bioreductive alkylating agent selected for further evaluation

April 20, 1999

BNP-7787 protects against taxane- and platinum-associated neurotoxicity

April 20, 1999

Further phase I data presented for bizelesin at AACR meeting

April 20, 1999

Structural Bioinformatics awarded SBIR grant for HER2 antagonists

April 20, 1999

News from AACR: 9-NC does not require conversion to 9-AC to exert antitumor activity

April 19, 1999

NX-211 compared to free lurtotecan regarding pharmacokinetics, toxicity and efficacy

April 19, 1999

CD-437: new apoptogenic retinoid examined for resistance using leukemia cells

April 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...